E3508: Randomized trial of carboplatin (C), paclitaxel (P), bevacizumab (B) with or without cixutumumab (Cx) in patients (pts) with advanced non-squamous, non-small cell lung cance... von Argiris, Athanassios, Lee, Ju-Whei, Stevenson, James, Sulecki, Matthew Gerard, Hugec, Vladimir, Choong, Nicholas W., Saltzman, Joel N., Song, Wei, Hansen, Richard M., Evans, Tracey L., Ramalingam, Suresh S., Schiller, Joan H.

Volltext

A phase 2 trial of regorafenib as a single agent in patients with chemotherapy refractory advanced and metastatic biliary adenocarcinoma/cholangiocarcinoma von Sun, Weijing, Normolle, Daniel Paul, Bahary, Nathan, Ohr, James, Lembersky, Barry C., Patel, Krishna, Patel, Anuj K., Lee, James J., Chu, Edward, Streeter, Natalie, Drummond, Summer, Morcos, John P., Sulecki, Matthew Gerard, Geller, David A., Marsh, J. Wallis, Tsung, Allan, Zeh, Herbert

Volltext

Phase 2 study of irinotecan and paclitaxel in patients with recurrent or refractory small cell lung cancer von Ramalingam, Suresh S., Foster, Judy, Gooding, William, Evans, Terry, Sulecki, Matthew, Belani, Chandra P.

Volltext

Phase I/II study of rilotumumab (R) and erlotinib (E) in previously treated patients (pts) with metastatic NSCLC von Tarhini, Ahmad A., Rafique, Imran, Tran, Phu, Gooding, William E., Villaruz, Liza Cosca, Burns, Timothy Francis, Friedland, David, Tarabay, Grace R., Laman, Andrew D., Mehta, Dhaval R., Sulecki, Matthew Gerard, Petro, Daniel P., Georgiadis, Mark S., Kane, Kevin M., Peracha, Sajid M., Rajasenan, Kiran K., Megaludis, Alexis, Dai, Lijun, Socinski, Mark A.

Volltext

Treatment of ganciclovir-induced neutropenia with recombinant human GM-CSF von Sulecki, Matthew, Rosenfeld, Craig S., Przepiorka, Donna, Bloom, Elana J., Buhles, William, Shadduck, Richard K.

Volltext

Treatment of ganciclovir-induced neutropenia with recombinant human GM-CSF von Sulecki, Matthew, Rosenfeld, Craig S., Przepiorka, Donna, Bloom, Elana J., Buhles, William, Shadduck, Richard K.

Volltext